Avantor's Stock Declines Despite Q3 Earnings Beat, Margins Down
Despite AVTR's continued stability in the Education and Advanced Technology end markets, it reports an overall soft third-quarter performance.
Avantor Inc. (AVTR) Q3 2024 Earnings Call Transcript
Avantor Inc. (NYSE:AVTR ) Q3 2024 Earnings Conference Call October 25, 2024 8:00 AM ET Company Participants Christina Jones - VP, IR Michael Stubblefield - President and Chief Executive Officer Brent Jones - Executive Vice President and Chief Financial Officer Conference Call Participants Daniel Brennan - TD Cowen Douglas Schenkel - Wolfe Research Tycho Peterson - Jefferies Michael Ryskin - Bank of America Vijay Kumar - Evercore ISI Daniel Leonard - UBS Conor McNamara - RBC Capital Markets Daniel Arias - Stifel Rachel Vatnsdal - JP Morgan Luke Sergott - Barclays Tejas Savant - Morgan Stanley Operator Good morning. My name is Emily, and I will be your conference operator today.
Avantor (AVTR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Avantor (AVTR) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Avantor, Inc. (AVTR) Beats Q3 Earnings Estimates
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.25 per share a year ago.
AVTR Stock Flat Following the Close of Divestiture Deal With Audax
Avantor closes its deal with Audax to divest its clinical services business.
MD vs. AVTR: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or Avantor, Inc. (AVTR). But which of these two stocks offers value investors a better bang for their buck right now?
Broyhill's Q2 2024 Top Five Investments
Our top five investments—Avantor, Baxter, Fiserv, Nintendo, and Philip Morris—represented 50% of the equity portfolio, with mixed performance during the quarter. Avantor's shares rallied 26% in July after a strong earnings report, reaffirming full-year guidance and showing signs of industry recovery. Baxter's shares increased significantly post-earnings, demonstrating portfolio durability and organic growth, prompting us to accumulate shares at attractive valuations.
Avantor (AVTR) Inks Deal to Optimize Portfolio, Reduce Debt
Avantor's (AVTR) latest agreement is likely to enhance its focus on strategic growth opportunities and reduce its debt burden.
Avantor's (AVTR) Q2 Earnings Beat, Operating Margin Declines
Avantor's (AVTR) revenues decline in the second quarter with new segmental changes. Bioprocessing orders decline.
Avantor Analysts Increase Their Forecasts After Better-Than-Expected Earnings
Avantor, Inc. AVTR reported better-than-expected second-quarter earnings results on Friday.
Avantor, Inc. (AVTR) Q2 Earnings and Revenues Beat Estimates
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.28 per share a year ago.
Analysts Estimate Avantor, Inc. (AVTR) to Report a Decline in Earnings: What to Look Out for
Avantor (AVTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
